Table 1 Statistically significant associations of neurological conditions and severe disease status after admission (pFDR < 0.05).
From: Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19
Neurological condition (ICD-10 code) | LOEa | RRDb (%) | RRD 95% CI (%) | pFDR |
|---|---|---|---|---|
Blindness and low vision (H54) | − 0.38 | − 23 | (− 33, − 11) | 2.0 × 10–4 |
Dizziness and giddiness (R42) | − 0.47 | − 28 | (− 33, -22) | 6.3 × 10–19 |
Encephalitis, myelitis and encephalomyelitis (G04) | 0.45 | 37 | (17, 60) | 0.0081 |
Nontraumatic intracerebral hemorrhage (I61) | 0.45 | 36 | (23, 51) | 3.6 × 10–5 |
Nontraumatic subarachnoid hemorrhage (I60) | 0.35 | 28 | (10, 48) | 0.019 |
Other and unspecified myopathies (G72) | 0.78 | 72 | (67, 77) | 8.8 × 10–45 |
Other and unspecified nontraumatic intracranial hemorrhage (I62) | 0.43 | 34 | (20, 50) | 3.0 × 10–4 |
Other cerebrovascular diseases (I67) | 0.31 | 24 | (13, 35) | 2.0 × 10–4 |
Other disorders of the brain (G93) | 0.44 | 36 | (32, 40) | 5.6 × 10–73 |
Other headache syndromes (G44) | − 0.91 | − 47 | (− 59, − 31) | 9.4 × 10–9 |
Other symptoms and signs involving cognitive functions and awareness (R41) | 0.28 | 22 | (19, 25) | 2.1 × 10–39 |
Transient cerebral ischemic attacks and related syndromes (G45) | − 0.85 | − 45 | (− 56, − 31) | 5.0 × 10–10 |
Unspecified psychosis not due to a substance or known physiological condition (F29) | − 0.84 | − 44 | (− 57, − 28) | 7.7 × 10–8 |
